A Live Satellite Symposium held during the 81st American Association of
Neurological Surgeons (AANS) Annual Scientific Meeting

Monday, April 29, 2013
6:30 PM – 8:30 PM
New Orleans Marriott Hotel
555 Canal Street
New Orleans, LA 70130

Room: Bissonet Ballroom

Faculty

Peter Le Roux, MD, FACS (Chair)
Associate Professor of Neurosurgery
Department of Neurosurgery
University of Pennsylvania
Philadelphia, PA

Charles V. Pollack, Jr, MA, MD, FACEP
Professor
Department of Emergency Medicine
Perelman School of Medicine
University of Pennsylvania
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Philadelphia, PA

Neurosurgeons are intimately involved in the emergency management of anticoagulant-treated patients who present with an intracerebral hemorrhage requiring urgent correction of their coagulopathy to prevent worsening hemorrhage and to facilitate surgical intervention as necessary. A number of therapies have been used alone or in combination for the treatment of AAICH to reverse anticoagulation in order to achieve hemodynamic stability, limit hematoma expansion, and prepare the patient for potential neurologic surgery. Given the essential role of the neurosurgeon, in consult with the emergency department physician, in managing these patients, this case-based, audience-interactive symposium will elucidate warfarin reversal strategies (and related current controversies) with available and soon-to-be-available therapies for the management of AAICH, and the importance of timely intervention in order to achieve successful reversal of warfarin-induced coagulopathy.

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Apply appropriately evidence-based guidelines and strategies to the management of patients with warfarin-associated ICH.
     
  • Recognize the barriers to successful management of patients with ICH in the context of anticoagulation-associated coagulopathy and, based on risk/benefit analysis of reversal agents, select appropriate therapies for the treatment of patients with AAICH.

Symposium Agenda
6:30 PM – 7:00 PM     Complimentary Dinner and Registration        

7:00 PM – 7:10 PM     Welcome/Introduction             

7:10 PM – 7:50 PM     Approaching the Management of AAICH

7:50 PM – 8:20 PM     Paths to Successful Management of AAICH

8:20 PM – 8:30 PM     Q &A


Target Audience
This activity has been designed to meet the educational needs of neurosurgeons, residents, fellows,  international neurosurgeons, neurosurgical nurses, and physician assistants interested in the practice and business of neurosurgery.

Accreditation & Credit Designation Statements
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support
This CME activity is supported by an educational grant from CSL Behring.

Disclosure
In accordance with ACCME requirements on disclosure, information about relationships with commercial interests (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity.   

Auxiliary Aids
If you need any of the auxiliary aids or services identified in the Americans with Disabilities Act in order to attend this program, or if you have any other special needs, please call (845) 398-5100.